Check out STAT’s exclusive breakthrough devices tracker.
The latest medical devices to receive breakthrough status from the Food and Drug Administration range across conditions, with several treating cardio and neurovascular conditions.
The FDA’s breakthrough devices program is designed to speed the path to market for novel, potentially lifesaving products. It gives manufacturers better access to regulators and the ability to design more flexible clinical trials. All manufacturers have to do is prove to the FDA that their product may someday “more effectively” treat or diagnose a debilitating disease.
This article is exclusive to STAT+ subscribers
Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.
Already have an account? Log in
